All In Biotech

Drug Trial Radar · NCT00050791

Effects of Leptin Treatment on Weight Loss

Leptin Treatment for Prevention of the Metabolic and Endocrine Sequelae of a Decreased Caloric Intake: Studies of Patients on a Very Low Calorie Diet

Last checked: Nov 20, 2026Latest source record: Oct 19, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Planned (sponsor's estimate)

Start

Mar 2001

Primary completion

Nov 2006

Study completion Jun 2009

Sponsor

Lead sponsor
Rockefeller UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Weill Medical College of Cornell University; St. Luke's-Roosevelt Hospital Center; Columbia University
First posted
Dec 23, 2002

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Female only, from 20 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a double blind placebo controlled clinical study designed to determine the effects of leptin on the changes that occur in the body during weight loss achieved by a very low calorie diet.

Conditions

  • Obesity

Interventions

  • LeptinDrug

    Leptin is an adipocyte hormone that functions as an afferent signal in a feedback loop regulating body weight

  • Very Low Calorie DietBehavioral

    placebo injections

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. energy expenditure after 10% and 20% weight loss, achieved by a VLCD with or without A-100 treatmentTime frame: Testing period 2,3 and 4 after 10% and 20% weight loss

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rockefeller University Hospital

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.